DRUG GUIDELINE

Magnesium Sulfate (Obstetric)
SCOPE (Area): Maternity Unit, Emergency, Operating Suite, ICU, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), Cardiovascular Suite, (Exclude: Coronary Care Unit)
SCOPE (Staff): Medical, Nursing, Midwifery, Pharmacy
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice) and General Wards


Preamble

See Appendix 1 - Magnesium Sulfate (Obstetric) for full version of this Drug Guideline.


Related Documents

CPP0119 - Hypertension Disorders In Pregnancy - Pre-Eclampsia/Eclampsia
DRG0005 - Calcium Gluconate
DRG0001 - Magnesium Sulphate (Non-obstetric)
CPP0222 - User Applied Labelling Of Injectable Medicines, Fluids And Lines
CPP0544 - Intravenous Drug Administration And Classification List
POL0077 - Medication Management
CPP0549 - High Risk Medications
CPP0473 - Alaris Intravenous Infusion System With Guardrails Medication And Fluid Management Software
SOP0001 - Principles Of Clinical Care


References

CRC Press Taylor & Francis Group. (2019). Renal Drug Database. Retrieved December 22, 2019 from
IBM Corporation. (2019). IBM Micromedex. Retrieved December 22, 2019, from
MIMS Online. (2019, December). MIMS Online, DBL Magnesium Sulfate Concentrated Injection. Retrieved December 22, 2019, from
MIMS Online. (2019, December). MIMS Online, Magnesium Sulfate Injection 50%. Retrieved December 22, 2019, from
Monash Health (2019, September). Hypertensive disorders in pregnancy, pre-eclampsia, eclampsia Clinical Guideline. Personal communication received Feb 10, 2020.
Queensland Government (2015, August), Queensland Clinical Guideline – Hypertensive disorders of pregnancy. Accessed on December 22, 2019 from
Rossi, S. (2019, July). Australian Medicines Handbook. Retrieved September 10, 2019, from
The Royal Women’s Hospital, Pharmacy Department (2019). Pregnancy and Breastfeeding Medicines Guide. Retrieved December 22, 2019 from
The Society of Hospital Pharmacists of Australia. 2019. Australian Injectable Drugs Handbook (7th ed.). Retrieved December 22, 2019, from
The Women’s (2018, November). Hypertension - Management of acute. Retrieved December 22, 2019 from
The Women’s (2018, November). Pre-Eclampsia: Management. Retrieved December 22, 2019 from
The Women’s (2019, February). Magnesium Sulfate - Management of Hypertensive Disorders of Pregnancy. Retrieved December 22, 2019 from
Therapeutic Guidelines Limited. (2019, December). Therapeutic Guidelines. Retrieved December 22, 2019, from
Walters Kluwer. (2019). UpToDate, Drug Interaction section. Retrieved December 22, 2019, from


Appendix

Appendix 1 - Magnesium sulfate (Obstetric)



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 30/09/2020
Review Responsibility: Pharmacist - Rotational Date for Review: 30/06/2025
Magnesium Sulfate (Obstetric) - DRG0036 - Version: 7 - (Generated On: 26-05-2025 05:59)